Traditional approaches to Reference Intervals
|
|
- Marcus Baker
- 5 years ago
- Views:
Transcription
1 Establishing reference intervals: Unique challenges for the pediatric population Amy L. Pyle, PhD, DABCC Traditional approaches to Reference Intervals Decision Limits Establish Verify Transfer 1
2 Decision Limits Set by national and international consensus groups for certain analytes Cholesterol, HbA1C guidelines Labs can adopt these Manufacturer should demonstrate traceability and verify accuracy Little R, Rohlfing C. HbA1c. An overview of current analytical testing issues. Clin Lab News. 2011;37(2):8 10 Establishing Intervals Lower and upper limits for the central 95% of the normal/study population 5% of normal persons will fall outside the interval Parametric estimation: assumes Gaussian distribution Non parametric: no assumptions about distribution 2
3 Results Distribution: Gaussian Central 95% Parametric Method of Interval Establishment: Central 95% of normal results is Reference Interval Not recommended, as most distribution is not Gaussian. Results Distribution: Non Gaussian Non Parametric method is preferred. For small sample size, use robust method (CLSI C28 A3c). 3
4 Establishing Intervals CLSI C28 A3c endorses this method as the best way for labs to generate RI s 120 samples for each partition (age, gender) Not practical for most laboratories Partitioning Partitions are characteristics of the population which can be used to break the reference intervals into subgroups. Partitioning between subgroups is warranted when the means between two groups are significantly different Most commonly age and gender Others: blood type, circadian variation, exercise, posture, menstrual stage, pregnancy 4
5 Verify Ranges CLSI C28 A3c recommends this as a more reasonable approach to reference intervals Requires a few as 20 samples from healthy individuals If 90% (18/20) samples are within the tested range, then that range can be accepted. If 2 3 samples are out of the range, re examine samples and analytical method. If >3 samples are out of the range, lab should consider establishing its own range Methodology Considerations Method specific Sodium = Sodium = Sodium TSH TSH TSH When finding ranges to verify, be sure to consider the methodology used to establish those ranges Immunoassay vs. mass spec Variation between manufacturers Use CAP peer group data for a rough idea of how methods compare 5
6 Use CAP Participant Summaries Use CAP Participant Summaries Caveats: No CAP survey, no method peer group From K C
7 Verify Ranges Are there even good pediatric reference ranges out there to verify? Soldin SJ, Wong EC, Brugnara C, Soldin OP, eds. Pediatric Reference Intervals, 7 th ed. Washington D.C.: AACC Press; 2011 Ashwood ER, ed. ARUP s Guide to Pediatric Clinical Laboratory Testining, 3 rd ed. Salt Lake City, UT: ARUP Laboratories; 2004 Meites S, ed. Pediatric Clinical Chemistry: Reference Values, 3 rd ed. Washington D.C.: AACC Press; Literature searches Do you have to verify ALL the partitions? Transfer Ranges Particularly useful when changing methodologies or adapting a reference interval from another methodology Need to establish comparability of assays Run method validation (see CLSI EP09) Linear Regression Slope ~ 1.0, Intercept ~0.0, correlation ~1.0: Accept ranges Intercept ~0.0, Correlation ~1.0: Correct ranges based on slope (bias) 7
8 Transfer Ranges Test X: Gold Standard Method Reference Interval: g/dl Run method comparison to new method: Transfer Ranges Test X: Gold Standard Method Reference Interval: g/dl Run method comparison to new method: 8
9 Transfer Ranges Test X: Gold Standard Method Reference Interval: g/dl Run method comparison to new method: Slope is nearly 1.0, intercept is nearly 0.0, correlation = Transfer Gold Standard Method Range to New Method Transfer Ranges Test Y: Gold Standard Method Reference Interval: g/dl Run method comparison to new method: 9
10 Transfer Ranges Test Y: Gold Standard Method Reference Interval: g/dl Run method comparison to new method: Slope is nearly 0.87, intercept is low, correlation = Apply slope to Gold St. Interval: 50 x 0.87= x 0.87 = What s unique about pediatric reference intervals? Kids aren t little adults Different metabolism Analytes changes during growth and maturation 10
11 What s unique about pediatric reference intervals? Analytes changes during growth and maturation What s unique about pediatric reference intervals? Need to partition by ages and gender What about Tanner Stages? Developmental stages, not age Particularly useful for evaluating analytes known to change during sexual maturation Requires thorough physical exam to determine 11
12 Challenges in Pediatric Reference Intervals Difficult to get lots of samples from truly normal children Especially across different age groups Small sample volumes Hoffman approach Real Life Example New Developments Difficult to get truly normal samples Could do a call for normal samples and bank them for future use Logistically challenging and expensive PRRC and National Children s Study 12
13 Difficult to get truly normal samples Could do a call for normal samples and bank them for future use Logistically challenging and expensive PRRC and National Children s Study Identify outpatients who are having routine lab work AAP screening recommendations Make sure tube types are compatible! American Academy of Pediatrics Screening Recommendations 13
14 Difficult to get truly normal samples Could do a call for normal samples and bank them for future use Logistically challenging and expensive PRRC and National Children s Study Identify outpatients who are having routine lab work AAP screening recommendations Make sure tube types are compatible! Normal results for a related parameter RetHe: samples with normal H&H, MCV, Ferritin Hoffman approach Use results from samples ordered for the test of interest (in and out patients) Better for validating, rather than establishing ranges Courtesy of Patti Jones 14
15 Real Life Example: IPF Switching TSH methodology within lab Previous ranges: Age 0 7 days 7 days 1 mo 1 mo 1 yr 1 yr 11 yr >11 yrs TSH (miu/ml) We don t know exactly where these came from! (REMINDER: Keep clear documentation of reference interval studies! Should be part of new assay validation information.) Real Life Example: TSH 15
16 Compare to CAP Peer Groups From K C 2012 Real Life Example: TSH 16
17 Real Life Example: TSH Use Slope as Multiplier Previous Ranges Age TSH (miu/ml) 0 7 days 7days 1 mo 1mo 1 yr 1 yr 11 yr >11 yrs X 0.87 Ranges multiplied by slope Age TSH (miu/ml) 0 7 days 7days 1 mo 1mo 1 yr 1 yr 11 yr >11 yrs Real Life Example: TSH Verify this by establishing range for one partition Previous Ranges Age TSH (miu/ml) 0 7 days 7days 1 mo 1mo 1 yr 1 yr 11 yr >11 yrs Choose 0 7 day group, since infants are routinely screened for elevated bilirubin (and we already made sure that icterus wouldn t interfere) Ran ~120 samples 17
18 Real Life Example: TSH Previous Ranges Age TSH (miu/ml) 0 7 days 7days 1 mo 1mo 1 yr 1 yr 11 yr >11 yrs X 0.87 Ranges multiplied by slope Age TSH (miu/ml) 0 7 days 7days 1 mo 1mo 1 yr 1 yr 11 yr >11 yrs Established Range 18
19 Real Life Example: TSH Ranges were generated!! Adult reference interval was verified using 20 healthy donors from the lab Physicians were consulted and notified (CAP All Common Checklist COM.40800) Direct to all endocrinologists Notice in the hospital wide newsletter Real Life Example: IPF Our lab wants to start offering IPF How do we establish our reference intervals? Significant logistical hurdles (Sample stability: 8 hrs) Very few other labs are offering this assay Totally novel assay (no method comparison) What reference range should we use? 19
20 Real Life Example: IPF What reference intervals should we use? Look to other labs & to the literature % % % Go through the options to create ranges: Establish Verify Transfer Real Life Example: IPF Establishing a range/verify a range It is still impractical to get 120 samples, but we did manage to get 54 samples Central 95% (parametric)= %, Transformed parametric = % Is the upper end too high? 20
21 Hoffman approach Use results from samples ordered for the test of interest (in and out patients) Better for validating, rather than establishing ranges Courtesy of Patti Jones Real Life Example: IPF All patients with samples run in optical platelet chamber (until we had ~300 results) Take central 50% of results % Take central 95% of results Courtesy of Patti Jones 21
22 Real Life Example: IPF Clinical Correlation Use residual sample 167 patients with low PLTC Sorted based off of diagnosis 33 peripheral destruction M= decreased production M= abnormal distribution M= other M=11.4 Findings consistent with previous studies Courtesy of Patti Jones Real Life Example: IPF Our range studies are fairly consistent Final range: % 22
23 Summary Creating reference intervals Establish (120 samples/partition) Verify Transfer References CLSI. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline Third Ed. CLSI document C28 A3c. Wayne, PA: Clinical and Laboratory Standards Institute;
24 Thanks! 24
The Virtues and Pitfalls of Implementing a New Test
The Virtues and Pitfalls of Implementing a New Test James H. Nichols, Ph.D., DABCC, FACB Professor of Clinical Pathology, Microbiology and Immunology Associate Medical Director for Clinical Operations
More informationThe Whats and Hows of Reference Intervals. Graham Jones Department of Chemical Pathology St Vincent s Hospital, Sydney
The Whats and Hows of Reference Intervals Graham Jones Department of Chemical Pathology St Vincent s Hospital, Sydney Surabaya Indonesia 2016 Acknowledgements Reference Intervals - Summary What are they
More informationUSING THE ACCESS AMH ASSAY IN YOUR LABORATORY
INFORMATION BULLETIN USING THE ACCESS AMH ASSAY IN YOUR LABORATORY ///////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
More informationMETHOD VALIDATION: WHY, HOW AND WHEN?
METHOD VALIDATION: WHY, HOW AND WHEN? Linear-Data Plotter a,b s y/x,r Regression Statistics mean SD,CV Distribution Statistics Comparison Plot Histogram Plot SD Calculator Bias SD Diff t Paired t-test
More informationEstablishing Reference Intervals for Clinical Laboratory Test Results Is There a Better Way?
Clinical Chemistry / Estimating Reference Intervals Establishing Reference Intervals for Clinical Laboratory Test Results Is There a Better Way? Alex Katayev, MD, 1 Claudiu Balciza, 2 and David W. Seccombe,
More information(a) y = 1.0x + 0.0; r = ; N = 60 (b) y = 1.0x + 0.0; r = ; N = Lot 1, Li-heparin whole blood, HbA1c (%)
cobas b system - performance evaluation Study report from a multicenter evaluation of the new cobas b system for the measurement of HbAc and lipid panel Introduction The new cobas b system provides a point-of-care
More informationDiagnostic reagent for quantitative in vitro determination of Urea / Blood Urea Nitrogen in serum, plasma and urine by colorimetry.
2013/07/30 A93A01315AUS A11A01641 60 ml 15 ml Pentra C400 Diagnostic reagent for quantitative in vitro determination of Urea / Blood Urea Nitrogen in serum, plasma and urine by colorimetry. QUAL-QA-TEMP-0846
More informationLaboratory Testing for Pediatric Patients: Concerns, Challenges and Solutions
Laboratory Testing for Pediatric Patients: Concerns, Challenges and Solutions Joely Straseski PhD, MT(ASCP), DABCC, FACB Assistant Professor, University of Utah Medical Director, ARUP Laboratories Endocrinology
More informationMETHOD VALIDATION CASE
METHOD VALIDATION CASE METHOD VALIDATION PROTOCOL CLIA Regulation 493.1253 (2) 1.Accuracy (closeness to true/comparative method) 2.Precision (reproducibility) 3.Reference Interval 4.Reportable range (linearity,
More information1. PROTOCOL. Comparison Study Summary. Tuality Healthcare 324 SE 9 th Ave. Suite E Hillsboro, OR July 30, 2014
Comparison Study Summary Tuality Healthcare 324 SE 9 th Ave. Suite E Hillsboro, OR 97123 July 30, 2014 1. PROTOCOL This study was conducted on July 24 th, 2014 at Tuality Healthcare, Hillsboro, OR. The
More informationForum for Collaborative HIV Research External Validation of CD4 and Viral Load Assays Paris, France June 29, 2007
Forum for Collaborative HIV Research External Validation of CD4 and Viral Load Assays Paris, France June 29, 2007 Thomas J. Spira, M.D. International Laboratory Branch Global AIDS Program Centers for Disease
More informationQuality Initiative In Pathology. Harmonisation of Laboratory Testing
Quality Initiative In Pathology Harmonisation of Laboratory Testing Harmonisation: what do we mean? Agreement of test results irrespective of the method used or the testing laboratory Requires: Common
More informationIDEXX Catalyst One Chemistry Analyzer for In-house Measurement of Total Thyroxine (TT 4 ) Concentration in Serum from Dogs and Cats
IDEXX Catalyst One Chemistry Analyzer for In-house Measurement of Total Thyroxine (TT 4 ) Concentration in Serum from Dogs and Cats Authors: Kate Cote, Ph.D., Graham Bilbrough, MA, VetMB, CertVA, MRCVS,
More informationFor In Vitro Diagnostic Use
SYNCHRON System(s) Chemistry Information Sheet Lactate REF A95550 For In Vitro Diagnostic Use ANNUAL REVIEW Refer to Review and Revision Coversheet at the front of each method. PRINCIPLE INTENDED USE reagent,
More informationSCIEX Vitamin D 200M Assay for the Topaz System
The First FDA-Cleared LC-MS/MS Assay for Vitamin D SCIEX Vitamin D 200M Assay for the Topaz System The first FDA-cleared LC-MS/MS assay for Vitamin D Vitamin D is an important building block for human
More informationA validation study of after reconstitution stability of diabetes: level 1 and diabetes level 2 controls
A validation study of after reconstitution stability of diabetes: level 1 and diabetes level 2 controls Shyamali Pal R B Diagnostic Private Limited, Lake Town, Kolkata, India INFO ABSTRACT Corresponding
More informationHEMOCHRON. Whole Blood Coagulation Systems
HEMOCHRON Whole Blood Coagulation Systems Citrated Activated Partial Thromboplastin Time (APTT) Cuvette Correlation Protocol for HEMOCHRON Microcoagulation Instruments MSIG:131 10/06 Dear Medical Professional:
More information2014 Continuing Compliance Master Series Best Practices in Alternative Assessment of Performance
2014 Continuing Compliance Master Series Best Practices in Alternative Assessment of Performance Brad S. Karon, MD, PhD, FCAP November 19, 2014 www.cap.org Today s Presenter Brad S. Karon, MD, PhD, FCAP
More informationPediatric reference intervals for biochemical markers: gaps and challenges, recent national initiatives and future perspectives
In this issue: Recent Advances in Pediatric Laboratory Medicine Pediatric reference intervals for biochemical markers: gaps and challenges, recent national initiatives and future perspectives Houman Tahmasebi
More informationPerformance Characteristics of Eight Estradiol Immunoassays
Clinical Chemistry / EVALUATION OF EIGHT ESTRADIOL IMMUNOASSAYS Performance Characteristics of Eight Estradiol Immunoassays David T. Yang, MD, 1 William E. Owen, MT(ASCP), 2 Carol S. Ramsay, 3 Hui Xie,
More informationHemostasis Test Validation, Performance and Reference Intervals
Hemostasis Test Validation, Performance and Reference Intervals Richard A. Marlar, Ph.D. Pathology and Laboratory Medicine Oklahoma City VA Medical Center University of Oklahoma Health Sciences Center
More information1 PROTOCOL. Comparison Study Summary. Springs Memorial Hospital. Springs Memorial Hospital 800 W. Meeting St. Lancaster, SC (803)
Comparison Study Summary Springs Memorial Hospital 800 W. Meeting St. Lancaster, SC 29720 (803) 286-1480 February 10, 2016 1 PROTOCOL This evaluation was conducted on February 10, 2016 at Springs Memorial
More informationGlucose Analytical Comparability Evaluation of the YSI 2300 STAT Plus and YSI 2900D Biochemistry Analyzers
Glucose Analytical Comparability Evaluation of the YSI 2300 STAT Plus and YSI 2900D iochemistry Analyzers Life Sciences Data for Life. TM YSI Life Sciences White Paper 91 Authors: Kevin Schlueter, PhD,
More informationThe Use of Tests in Clinical Biochemistry Interpreting Blood Results. Rowland Reece Principal Clinical Biochemist St. Vincent s University Hospital
The Use of Tests in Clinical Biochemistry Interpreting Blood Results Rowland Reece Principal Clinical Biochemist St. Vincent s University Hospital Topic Headlines What is Clinical Biochemistry? How does
More informationVOICE (MTN-003) IT S ALL ABOUT THE ENDPOINTS. Edward Livant MT (ASCP), MPH University of Pittsburgh Medical Center MTN Network Laboratory
VOICE (MTN-003) IT S ALL ABOUT THE ENDPOINTS Edward Livant MT (ASCP), MPH University of Pittsburgh Medical Center MTN Network Laboratory Review of Sample 2 Testing starts here with rapid test (s). Negative
More informationWhat information on measurement uncertainty should be communicated to clinicians, and how? Mario Plebani
What information on measurement uncertainty should be communicated to clinicians, and how? Mario Plebani OUTLINE OF TALK Uncertainty in medicine and shared decision making Measurement uncertainty in laboratory
More informationDelta Check Calculation Guide
Delta Check Calculation Guide National Technology 2017, All Rights Reserved By Senior Scientific Researcher, Asmaa Taher Table of Contents Definition... 2 Purpose... 2 Delta Check Research Studies... 2
More informationPENN STATE MILTON S. HERSHEY MEDICAL CENTER TABLE OF CRITICAL LAB VALUES CURRENT AS OF: 1/2015
PENN STATE MILTON S. HERSHEY MEDICAL CENTER TABLE OF CRITICAL LAB VALUES CURRENT AS OF: 1/2015 Section: Chemistry For inpatients, once 3 consecutive critical values for the same analyte (test result) have
More informationEvaluation of Cheongmeak DCS TM Reagents for Chemistry Analyzers
임상검사와정도관리 J Lab Med Qual Assur 2010 ; 32:197-204 ISSN 1225-097X Evaluation of Cheongmeak DCS TM Reagents for Chemistry Analyzers Kyeong Seob Shin, Taek Eun Jeong, and Bo Ra Son Department of Laboratory
More informationliquicolor (AMP Buffer, IFCC) Design Verification
Design Verification (AMP Buffer, IFCC) liquicolor 1 Introduction... 2 2 Imprecision... 2 3 arity and Detection Limit... 2 3.1 arity... 2 3.2 Detection Limit... 3 4 Comparison of Methods... 3 5 Stability...
More informationBÜHLMANN fcal turbo. Calprotectin turbidimetric assay for professional use. Reagent Kit B-KCAL-RSET. Revision date:
BÜHLMANN fcal turbo Calprotectin turbidimetric assay for professional use Reagent Kit B-KCAL-RSET Revision date: 2017-02-24 BÜHLMANN LABORATORIES AG Baselstrasse 55 4124 Schönenbuch, Switzerland Tel.:
More informationAldosterone on Liaison XL In use date: June 6, 2017
Aldosterone on Liaison XL In use date: June 6, 2017 I. PRINCIPLE Aldosterone is a steroid hormone of molecular weight 360.4 daltons, the major mineralcorticoid secreted by the adrenal cortex. The role
More informationEssentials in Bioassay Design and Relative Potency Determination
BioAssay SCIENCES A Division of Thomas A. Little Consulting Essentials in Bioassay Design and Relative Potency Determination Thomas A. Little Ph.D. 2/29/2016 President/CEO BioAssay Sciences 12401 N Wildflower
More informationEvaluation Report: Eurolyser CRP test (ST0100 and ST0102) on. CUBE analyser (CA0100)
Evaluation Report: Eurolyser CRP test (ST0100 and ST0102) on CUBE analyser (CA0100) Location Location: Eurolyser Diagnostica GmbH Operators: Simone Wieser; Franz Helminger; Michael Gruber Date: July-November
More informationGLUH PRINCIPLE REF B ANNUAL REVIEW Reviewed by. Date. Date INTENDED USE
SYNCHRON System(s) Chemistry Information Sheet Copyright 2014 Beckman Coulter, Inc. GLUH Glucose REF B24985 For In Vitro Diagnostic Use Rx Only ANNUAL REVIEW Reviewed by Date Reviewed by Date PRINCIPLE
More informationAssessment of latest LFT guidelines from American College of Gastroenterology. Gus Koerbin
Assessment of latest LFT guidelines from American College of Gastroenterology Gus Koerbin Focus on ALT Review AACB current recommendations RI (examples) Bias Clinical Significance BMI AGC Guidelines Response
More informationHEALTH CARE EXPENDITURES ASSOCIATED WITH PERSISTENT EMERGENCY DEPARTMENT USE: A MULTI-STATE ANALYSIS OF MEDICAID BENEFICIARIES
HEALTH CARE EXPENDITURES ASSOCIATED WITH PERSISTENT EMERGENCY DEPARTMENT USE: A MULTI-STATE ANALYSIS OF MEDICAID BENEFICIARIES Presented by Parul Agarwal, PhD MPH 1,2 Thomas K Bias, PhD 3 Usha Sambamoorthi,
More informationREAD HIGHLIGHTED CHANGES
BIO-FLASH anti-hbs 3000-8581 100 tests The BIO-FLASH anti-hbs is a fully automated chemiluminescent simultaneous immunoassay for quantitative measurement of antibodies to Hepatitis B surface antigen (anti-hbs)
More informationMethod Comparison Report Semi-Annual 1/5/2018
Method Comparison Report Semi-Annual 1/5/2018 Prepared for Carl Commissioner Regularatory Commission 123 Commission Drive Anytown, XX, 12345 Prepared by Dr. Mark Mainstay Clinical Laboratory Kennett Community
More informationValidation Case studies: the good, the bad and the molecular
Validation Case studies: the good, the bad and the molecular Patti Jones PhD Professor of Pathology UT Southwestern Medical Center Director of Chemistry Children s Medical Center Dallas Presented by AACC
More informationReference Intervals for Intestinal Disaccharidase Activities Determined from a Non-Reference Population
Reference Intervals for Intestinal Disaccharidase Activities Determined from a Non-Reference Population Sarah A. Hackenmueller 1 and David G. Grenache 1,2 * Background: Cutoff activities for diagnosing
More information1.4 - Linear Regression and MS Excel
1.4 - Linear Regression and MS Excel Regression is an analytic technique for determining the relationship between a dependent variable and an independent variable. When the two variables have a linear
More informationMETHOD VALIDATION CASE
METHOD VALIDATION CASE METHOD VALIDATION PROTOCOL CLIA Regulation 493.1253 (2) 1.Accuracy (closeness to true/comparative method) 2.Precision (reproducibility) 3.Reference Interval 4.Reportable range (linearity,
More informationINSTRUCTIONS FOR USE
VITROS Chemistry Products Reagent 680 1728 Rx ONLY Intended Use For in vitro diagnostic use only. VITROS Chemistry Products Reagent is used on the VITROS 5,1 FS Chemistry System, the VITROS 4600 Chemistry
More informationHemoglobin A1c: Comparison of Pointe Scientific s 2-Part Direct Hemoglobin A1c with the Bio-Rad Variant II and the Tosoh G8
Hemoglobin A1c: Comparison of Pointe Scientific s 2-Part Direct Hemoglobin A1c with the Bio-Rad Variant II and the Tosoh G8 Joseph D. Artiss, Ph.D., FACB, Associate Professor of Pathology, Wayne State
More informationPerformance Characteristics of a New Single-Sample Freezing Point Depression Osmometer
AACC, July 2007 Performance Characteristics of a New Single-Sample Freezing Point Depression Osmometer E. Garry, M. Pesta, N. Zampa Advanced Instruments, Inc., Norwood, MA 02062 AbstracT The Advanced Model
More information2.0 Synopsis. Lupron Depot M Clinical Study Report R&D/09/093. (For National Authority Use Only) to Part of Dossier: Name of Study Drug:
2.0 Synopsis Abbott Laboratories Individual Study Table Referring to Part of Dossier: Name of Study Drug: Volume: Abbott-43818 (ABT-818) leuprolide acetate for depot suspension (Lupron Depot ) Name of
More informationFor in vitro diagnostic use only. For Rx use only. Reviewed by Date Reviewed by Date
AU US Instructions For Use 2018 Beckman Coulter, Inc. All rights reserved. TRIG TRIGLYCERIDE OSR60118 4 x 20 ml R1, 4 x 5 ml R2 OSR61118 4 x 50 ml R1, 4 x 12.5 ml R2 OSR66118 4 x 173 ml R1, 4 x 48 ml R2
More informationIn Vitro Diagnostic Glucose Test System
CDRH Final Guidance 2-Page Cover Sheet Guidance for Industry In Vitro Diagnostic Glucose Test System Document issued on: July 6, 1998 U.S. Department Of Health and Human Services Food and Drug Administration
More informationSpecimen Collection Requirements
The following is a job aid listing the specimen collection requirements for laboratory testing at Colchester East Hants Health Center. Specimens must be accompanied by the Patient Information Form G09.
More informationCommutability studies undertaken by the LNE : the case of lipid and lipoprotein testing. Vincent Delatour, PhD
Commutability studies undertaken by the LNE : the case of lipid and lipoprotein testing Vincent Delatour, PhD 1 Traceability in laboratory medicine : regulatory drivers Reform of medical biology in France
More informationObjective: To describe a new approach to neighborhood effects studies based on residential mobility and demonstrate this approach in the context of
Objective: To describe a new approach to neighborhood effects studies based on residential mobility and demonstrate this approach in the context of neighborhood deprivation and preterm birth. Key Points:
More informationChoosing a Significance Test. Student Resource Sheet
Choosing a Significance Test Student Resource Sheet Choosing Your Test Choosing an appropriate type of significance test is a very important consideration in analyzing data. If an inappropriate test is
More information1 PROTOCOL. Comparison Study Summary
Comparison Study Summary OnSite Health 210 S. Michigan Street, Suite 110 South Bend, IN 46601 574-243-5108 ext. 203 July 27, 2015 1 PROTOCOL This internal evaluation was conducted on July 17 & 20, 2015
More informationLIPASE liquicolor. Design Verification. Multipurpose Reagent
Design Verification LIPASE liquicolor Multipurpose Reagent CONTENTS 1 Introduction... 2 2 Imprecision... 2 3 Linearity and Detection Limit... 2 3.1 Linearity... 2 3.2 Detection Limit... 3 4 Recovery of
More informationHbA1c3 PRINCIPLE REF B ANNUAL REVIEW Reviewed by. Date. Date INTENDED USE
SYNCHRON System(s) Chemistry Information Sheet Copyright 2014 Beckman Coulter, Inc. HbA1c3 Hemoglobin A1c3 REF B36415 For In Vitro Diagnostic Use Rx Only ANNUAL REVIEW Reviewed by Date Reviewed by Date
More informationINSTRUCTIONS FOR USE
INSTRUCTIONS FOR USE VITROS Chemistry Products malb Reagent malb 680 1740 Rx ONLY Intended Use For in vitro diagnostic use only. VITROS Chemistry Products malb Reagent is used on the VITROS 5,1 FS Chemistry
More informationIntroduction. Study Objective. Methodology. Results. Data Analysis. Interpretation
WHITE PAPER COMPARISON STUDY BETWEEN THE HETTICH EBA 200S (HP) BLOOD TUBE PACKAGE 8 (FORMALLY HELMER QUICKSPIN PLUS) AND A TRADITIONAL 3 LITER CENTRIFUGE IN BLOOD CHEMISTRY DETERMINATIONS Introduction
More information4/20/2015. Serum Protein Tumor Marker Assays: A Need for Constant Vigilance. Learning Objectives. Estimated Cancer Deaths in the US in 2015
Serum Protein Tumor Marker Assays: A Need for Constant Vigilance Nichole Korpi-Steiner, PhD, DABCC, FACB University of North Carolina Chapel Hill, NC Learning Objectives Describe what comprises an ideal
More informationEvidence Based Commutability: Bias 2 Study. Janice Gill Manager RCPAQAP Chemical Pathology Adelaide SA
Evidence Based Commutability: Bias 2 Study Janice Gill Manager RCPAQAP Chemical Pathology Adelaide SA Australian Bias Studies conducted by Gus Koerbin, ACT Pathology on behalf of AACB Harmonisation Committee
More informationIt s a Gas! Issues in the Blood Gas Laboratory. D. Robert Dufour, MD, FCAP Consultant Pathologist VA Medical Center, Washington DC
It s a Gas! Issues in the Blood Gas Laboratory D. Robert Dufour, MD, FCAP Consultant Pathologist VA Medical Center, Washington DC Learning Objectives After participating in this session, you will be able
More informationGuide to Fulfillment of Measurement Uncertainty
DIAGNOSTIC ACCREDITATION PROGRAM College of Physicians and Surgeons of British Columbia 300 669 Howe Street Telephone: 604-733-7758 ext. 2635 Vancouver BC V6C 0B4 Toll Free: 1-800-461-3008 (in BC) www.cpsbc.ca
More informationIntroduction. Study Objective. Methodology. Results. Data Analysis. Interpretation
WHITE PAPER COMPARISON STUDY BETWEEN THE HETTICH EBA200S (HP) BLOOD TUBE PACKAGE 8 (FORMERLY QUICKSPIN PLUS) AND A SMALL CLINICAL CENTRIFUGE IN BLOOD CHEMISTRY DETERMINATIONS Introduction The Hettich EBA
More informationTwo Important Statistics
Two Important Statistics 70% 40% 0 Quality Control & YOU David Plaut Fall, 2012 davidplaut@yahoo.com 1 11 Why do physicians order laboratory tests? 2 2 Why do Physicians Order Laboratory Tests? 1. Patients
More informationSimple Linear Regression
Simple Linear Regression Assoc. Prof Dr Sarimah Abdullah Unit of Biostatistics & Research Methodology School of Medical Sciences, Health Campus Universiti Sains Malaysia Regression Regression analysis
More informationResults Report. Welcome to Your ABT Report! Introduction to the ABT Report
Results Report Athlete Name: SHEPPARD, JOSEPH Date of Blood Draw: Dec 08, 2017 Panel: ABT Gold Panel ABT Expert: Dr. Rock Welcome to Your ABT Report! Thank you for trusting AthleteBloodTest.com to be a
More informationOverview of the AACC Academy s LMPG: Using clinical laboratory tests to monitor drug therapy in pain management patients
Overview of the AACC Academy s LMPG: Using clinical laboratory tests to monitor drug therapy in pain management patients Gwen McMillin, PhD, DABCC(CC,TC) Professor, University of Utah Medical Director,
More informationBIOLOGICAL VARIABILITY: THE CIRME CONTRIBUTION. F. Braga Centre for Metrological Traceability in Laboratory Medicine (CIRME)
BIOLOGICAL VARIABILITY: THE CIRME CONTRIBUTION F. Braga Centre for Metrological Traceability in Laboratory Medicine (CIRME) TOTAL VARIATION (CV (CV T ) T ) PREANALYTICAL VARIATION ANALYTICAL VARIATION
More informationRegression Including the Interaction Between Quantitative Variables
Regression Including the Interaction Between Quantitative Variables The purpose of the study was to examine the inter-relationships among social skills, the complexity of the social situation, and performance
More informationUREA CE Insert. 01 English - Ref.: 27. Ref.:27
UREA CE Insert Ref.:27 Intended use. Colorimetric and enzymatic system for urea determination in samples of blood and urine, by end point reaction. Professional use. [Only for in vitro diagnostic use.]
More informationModule 3: Overview of HIV Testing Technologies
Module 3: Overview of HIV Testing Technologies Purpose Pre-requisite Modules Module Time Learning Objectives To provide the participants with a basic knowledge of HIV testing and how HIV rapid test results
More informationSetting of quality standards
Setting of quality standards Graham Jones Department of Chemical Pathology St Vincent s Hospital, Sydney AACB ASM Adelaide October 2014 Setting of Quality Standards - 2013 The 2013 QC workshop revealed
More informationPolymer Technology Systems, Inc. CardioChek PA Comparison Study
Polymer Technology Systems, Inc. CardioChek PA Comparison Study Evaluation Protocol: Accuracy Precision Clinical Correlation PTS Panels Lipid Panel Test Strips For Use in Comparisons to a Reference Laboratory
More informationBias in clinical chemistry. Elvar Theodorsson EFLM and Linköping University
Bias in clinical chemistry Elvar Theodorsson EFLM and Linköping University Bias a controversial subject Different perspectives Reseachers Users Regulatory bodies Standardisation organisations Metrologists
More informationIDEXX Catalyst SDMA Test for in-house measurement of SDMA concentration in serum from dogs and cats
IDEXX Catalyst SDMA Test for in-house measurement of SDMA in serum from dogs and cats By Graham Bilbrough, Barbara Evert, Karen Hathaway, Gina Panagakos, Jane Robertson, and Maha Yerramilli Introduction
More informationMidMichigan Health LABORATORY POLICY Title: Effecti ve te: Key Words: places: Category: Applicability: reference laboratory
Page 1 of 5 PURPOSE This policy describes the responsibilities for determining which tests performed and or provided by the MidMichigan Health Laboratories fulfill the criteria for critical values / critical
More informationBasic knowledge of POCT instuments. The Tide Resort Bangsan Beach 18 June 2009
Basic knowledge of POCT instuments The Tide Resort Bangsan Beach 18 June 2009 1 POCT instruments concepts Point of care testing Diagnostic medical devices used at or near the site of patient care Bed site,
More informationThe Pretest! Pretest! Pretest! Assignment (Example 2)
The Pretest! Pretest! Pretest! Assignment (Example 2) May 19, 2003 1 Statement of Purpose and Description of Pretest Procedure When one designs a Math 10 exam one hopes to measure whether a student s ability
More informationFreeStyle Lite A Blood Glucose Meter That Requires No Coding
Journal of Diabetes Science and Technology Volume 2, Issue 4, July 2008 Diabetes Technology Society SYMPOSIUM Shridhara, Ph.D. Abstract Background: Abbott Diabetes Care introduced the FreeStyle Lite blood
More informationDisclosures. Obesity and Its Challenges: Outline. Outline 5/2/2013. Lan Vu, MD Division of Pediatric Surgery Department of Surgery
Obesity and Its Challenges: Bariatric Surgery: Why or Why Not I have nothing to disclose Disclosures Lan Vu, MD Division of Pediatric Surgery Department of Surgery Outline Growing obesity epidemic Not
More informationHarmonization of Clinical Laboratory Results is Essential for Quality Patient Care
Harmonization of Clinical Laboratory Results is Essential for Quality Patient Care Greg Miller, PhD Virginia Commonwealth University Richmond, VA Presented at the National Association of Chronic Disease
More informationSpecimen Collection Requirements
The following is a job aid listing the specimen collection requirements for laboratory testing at Colchester East Hants Health Center. Specimens must be accompanied by the Patient Information Form G09.
More informationPEDIATRIC PREVENTIVE HEALTH GUIDELINES
PEDIATRIC PREVENTIVE HEALTH GUIDELINES Each child and family is unique; therefore, these Guidelines for Preventive Pediatric Health Care are designed for the care of children who are receiving competent
More informationLecture 6B: more Chapter 5, Section 3 Relationships between Two Quantitative Variables; Regression
Lecture 6B: more Chapter 5, Section 3 Relationships between Two Quantitative Variables; Regression! Equation of Regression Line; Residuals! Effect of Explanatory/Response Roles! Unusual Observations! Sample
More informationCalibration of High-Density Lipoprotein Cholesterol Values From the Korea National Health and Nutrition Examination Survey Data, 2008 to 2015
Original Article Clinical Chemistry Ann Lab Med 217;37:1-8 https://doi.org/1.3343/alm.217.37.1.1 ISSN 2234-386 eissn 2234-3814 Calibration of High-Density Lipoprotein Cholesterol Values From the Korea
More informationState of the Art of HbA1c Measurement
State of the Art of HbA1c Measurement XXI Congreso Latinoamericano de Patologia Clinica Y XLII Congreso Mexicano de Patologia Clinica, Cancun October 2012 Randie R. Little, Ph.D. NGSP Network Laboratory
More informationEvaluation of new MiniCollect Z Serum (Separator) Tubes
Evaluation of new MiniCollect Z Serum (Separator) Tubes Background: Greiner Bio-One has developed a newly designed MiniCollect tube offering an integrated collection scoop. The advantage of the new tube
More informationClinical Chemistry Specific Proteins Presentation
Clinical Chemistry Specific Proteins Presentation November 2004 AEROSET and c8000 are registered trademarks of Abbott Laboratories. All other trademarks, brands, trade names and product names are the property
More informationROUTINE HIV SCREENING
RT_Handbook_update 5/14/12 12:07 PM Page a How-to Guide for DC Medical Providers ROUTINE HIV SCREENING IMPLEMENTATION HANDBOOK RT_Handbook_update 5/14/12 12:07 PM Page b RT_Handbook_update 5/14/12 12:07
More informationMS&E 226: Small Data
MS&E 226: Small Data Lecture 10: Introduction to inference (v2) Ramesh Johari ramesh.johari@stanford.edu 1 / 17 What is inference? 2 / 17 Where did our data come from? Recall our sample is: Y, the vector
More informationOriginal Article Interfering effect of bilirubin on the determination of alkaline phosphatase
Int J Clin Exp Med 2014;7(11):4244-4248 www.ijcem.com /ISSN:1940-5901/IJCEM0002083 Original Article Interfering effect of bilirubin on the determination of alkaline phosphatase Zhong Wang, Hongyan Guo,
More informationCOG-ACNS1123: Phase 2 Trial of Response-Based Radiation Therapy for Patients with Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Page 1 of 6 COG-ACNS1123: Phase 2 Trial of Response-Based Radiation Therapy for Patients with Localized Central Nervous System Germ Cell Tumors (CNS GCT) FAST FACTS Eligibility Reviewed and Verified By
More informationPediatric and Adult Reference Intervals for Chemistry, Immunoassay, and Hematology Markers based on the CHMS
Pediatric and Adult Reference Intervals for Chemistry, Immunoassay, and Hematology Markers based on the CHMS Victoria Higgins, MSc Candidate CALIPER Project The Hospital for Sick Children, Toronto, Canada
More informationMultiple studies are available concerning the use of
SPECIAL ARTICLE Evaluation of the Biosite Ò Quantitative Whole Blood D-dimer Assay and Comparison With the biomérieux VIDAS Ò D-dimer Exclusion Test Validation and Utility For Use in the Central Laboratory
More informationImmunoCAP Systems. Optimized for allergy testing - Precision - Accuracy - Consistency
ImmunoCAP Systems Optimized for allergy testing - Precision - Accuracy - Consistency 1 The ImmunoCAP systems from Phadia offer an optimal allergy testing solution for every laboratory, regardless of testing
More informationBLOOD GLUCOSE METERS ACCURACY REQUIREMENTS
BLOOD GLUCOSE METERS ACCURACY REQUIREMENTS International Standard ISO 15197:2013 (Second Edition 15/05/2013) In vitro diagnostic test systems Requirements for blood-glucose monitoring systems for self-testing
More informationQuality Specifications for POCT
Quality Specifications for POCT the patient journey perspective Christopher P Price Department of Clinical Biochemistry, University of Oxford, Oxford, UK Quality Specifications fit-for-purpose QUALITY
More informationAgenda. 15 Dec
Implementing Traceability for Heterogeneous Analytes An Industry View JCTLM Symposium on Reference Measurement Systems for Biologicals, December 15, 2004 R. Miller 15 Dec. 2004 1 Agenda Recent trends in
More informationEarly and Periodic Screening, Diagnosis and Treatment (EPSDT)
Early and Periodic Screening, Diagnosis and Treatment (EPSDT) EPSDT and Bright Futures: Missouri MISSORI (MO) Medicaid s EPSDT benefit provides comprehensive health care services to children under age
More informationCAP Laboratory Improvement Programs. Utility of Repeat Testing of Critical Values. A Q-Probes Analysis of 86 Clinical Laboratories
CAP Laboratory Improvement Programs Utility of Repeat Testing of Critical Values A Q-Probes Analysis of 86 Clinical Laboratories Christopher M. Lehman, MD; Peter J. Howanitz, MD; Rhona Souers, MS; Donald
More information